Skip to main content
Caplight Logo









TruDataRx

TruDataRx

Private
VermontHealthcare & Life Scienceshttps://www.trudatarx.com/

Last Round

Angel

May 15, 2017

Total Funding Raised

$275,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

TruDataRx operates in Healthcare & Life Sciences and is based in Vermont. Its latest recorded funding round was an Angel round in May 2017.

TruDataRx is a healthcare data analytics company that provides comparative effectiveness research and evidence-based algorithms to help self-insured employers and plan sponsors optimize pharmacy benefit management and reduce drug spending.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Business Intelligence

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

TruDataRx Comparables

Compare TruDataRx with similar companies based on industry and business-model similarity.

TruDataRx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PBIRx, Inc.
86%
ARMSRx
78%
EmpiRx Health
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

TruDataRx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelMay 15, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Catalina Gorla

co-founder & CEO

Founding Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 47% MoM.

  • Jun 20, 2026

    Monthly visitors grew 211% MoM, reaching 4.1K.

Book a demo to see all signals

For institutional investors. Book with your work email.

TruDataRx Filings

Explore SEC and related filing metadata, where available.

TruDataRx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about TruDataRx's valuation, stock price, and market status.

Is TruDataRx a public or private company?

TruDataRx is a private company.

What is the current stock price of TruDataRx?

TruDataRx is a private company, so its shares have no public market price. Caplight tracks TruDataRx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is TruDataRx worth (valuation)?

Valuation information for TruDataRx is not publicly available.

Can I buy TruDataRx stock?

TruDataRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was TruDataRx's last funding round?

TruDataRx's most recent funding round was Angel on May 15, 2017.

Who are the main investors in TruDataRx?

Investor information for TruDataRx is not publicly disclosed.

Will TruDataRx IPO soon?

No public IPO plans have been announced for TruDataRx.

How can I track TruDataRx secondary market activity?

Caplight tracks bids, offers, and trades in TruDataRx's shares on secondary markets.

Firmographic Details

HeadquartersVermont
Employee Range64
Year Founded2017
Last FundingMay 15, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?